| Venmax Drugs & Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 531015 |
NSE Symbol : - |
P/E(TTM) : 32.93 |
|
ISIN Demat : INE154G01022 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.75 |
|
Book Value(₹) : 13.58 |
Market Cap(₹Cr) : 28.61 |
Face Value(₹) : 10.00 |
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 1.55 | 1.32 | 1.21 | 0.33 | 0.20 | 0.17 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1.55 | 1.32 | 1.21 | 0.33 | 0.20 | 0.17 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.07 | 0.00 | 0.00 | 1.02 | 0.00 | 0.00 |
| Total Income | 1.62 | 1.32 | 1.21 | 1.36 | 0.20 | 0.17 |
| Total Expenditure | 1.58 | 1.27 | 1.17 | 0.58 | 0.69 | 0.47 |
| PBIDT | 0.04 | 0.05 | 0.04 | 0.78 | -0.49 | -0.30 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDT | 0.04 | 0.05 | 0.04 | 0.78 | -0.49 | -0.30 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Tax | 0.01 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 0.03 | 0.02 | 0.04 | 0.78 | -0.50 | -0.30 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.03 | 0.02 | 0.04 | 0.78 | -0.50 | -0.30 |
| EPS (Unit Curr.) | 0.05 | 0.05 | 0.07 | 1.49 | -0.95 | -0.58 |
| EPS (Adj) (Unit Curr.) | 0.05 | 0.05 | 0.07 | 1.49 | -0.95 | -0.58 |
| Calculated EPS (Unit Curr.) | 0.04 | 0.03 | 0.07 | 1.49 | -0.95 | -0.58 |
| Calculated EPS (Adj) (Unit Curr.) | 0.04 | 0.03 | 0.07 | 1.49 | -0.95 | -0.58 |
| Calculated EPS (Ann.) (Unit Curr.) | 0.16 | 0.12 | 0.29 | 5.94 | -3.78 | -2.32 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 0.16 | 0.12 | 0.29 | 5.94 | -3.78 | -2.32 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 8.01 | 8.01 | 5.24 | 5.24 | 5.24 | 5.24 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 2.58 | 3.79 | 3.31 | 236.36 | -245.00 | -176.47 |
| PBDTM(%) | 2.58 | 3.79 | 3.31 | 236.36 | -245.00 | -176.47 |
| PATM(%) | 1.94 | 1.52 | 3.31 | 236.36 | -250.00 | -176.47 |
